Press Releases

Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a revised supply agreement with the government of South Korea for 20 million doses of Moderna's COVID-19 vaccine or an updated booster vaccine candidate, if authorized....

Global air cargo brand Turkish Cargo became the logistics solutions partner of Togg (Turkey's Automobile Joint Venture Group), which was founded with the mission of becoming Turkey's most valuable global mobility brand. National brand carries Turkey's first electric automobile...

Chiesi, the international research-focused pharmaceuticals and healthcare Group (Chiesi Group), presented today to the Italian Minister of Economic Development Giancarlo Giorgetti in Rome, the Biotech Center of Excellence Plant project, the new hub for the development of biological products....

SAB Biotherapeutics , a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, high-potency, fully-human polyclonal antibodies without the need for human donors, announced data demonstrating that SAB-185, the company’s therapeutic candidate for the treatment of...

CSafe Global, the leader in temperature-controlled container solutions for the pharmaceutical industry, announced that it has acquired Softbox Systems, a provider of passive temperature-controlled packaging solutions for the pharmaceutical, life science and cold chain logistics industries, significantly enhancing CSafe’s...

Novavax, Inc., a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, announced that the World Health Organization (WHO) has...

Valneva SE, a specialty vaccine company, announced positive homologous booster data from the Phase 1/2 study, of its inactivated, adjuvanted COVID-19 vaccine candidate, VLA2001. Initial results confirm that VLA2001 significantly boosted immunity in participants who received VLA2001 as a...